Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
View: Text | PDF
Research Article Vascular biology

mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice

  • Text
  • PDF
Abstract

Aortic dissection and rupture are triggered by decreased vascular wall strength and/or increased mechanical loads. We investigated the role of mTOR signaling in aortopathy using a well-described model of angiotensin II–induced dissection, aneurysm, or rupture of the suprarenal abdominal aorta in Apoe-deficient mice. Although not widely appreciated, nonlethal hemorrhagic lesions present as pseudoaneurysms without significant dissection in this model. Angiotensin II–induced aortic tears result in free rupture, contained rupture with subadventitial hematoma (forming pseudoaneurysms), dilatation, or healing, while the media invariably thickens regardless of mural tears. Medial thickening results from smooth muscle cell hypertrophy and extracellular matrix accumulation, including matricellular proteins. Angiotensin II activates mTOR signaling in vascular wall cells, and inhibition of mTOR signaling by rapamycin prevents aortic rupture but promotes dissection. Decreased aortic rupture correlates with decreased inflammation and metalloproteinase expression, whereas extensive dissection correlates with induction of matricellular proteins that modulate adhesion of vascular cells. Thus, mTOR activation in vascular wall cells determines whether aortic tears progress to dissection or rupture. Previous mechanistic studies of aortic aneurysm and dissection by angiotensin II in Apoe-deficient mice should be reinterpreted as clinically relevant to pseudoaneurysms, and mTOR inhibition for aortic disease should be explored with caution.

Authors

Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides

×

Figure 7

Rapamycin-insensitive CTGF inhibits SMC adhesion to exogenous ECM.

Options: View larger image (or click on image) Download as PowerPoint
Rapamycin-insensitive CTGF inhibits SMC adhesion to exogenous ECM.
(A) A...
(A) Apoe–/– mice were infused with saline or AngII with or without rapamycin (Rapa) treatment for 7 days and the suprarenal abdominal aortas were analyzed by Western blot for CTGF, thrombospondin-1 (TSP1), tenascin-C (TNC), phospho-S6 (p-S6), and S6. (B) Densitometry of protein expression relative to HSP90 or (C) phospho-S6 expression relative to S6; expression normalized to peak levels with AngII treatment alone, (n = 4). (D) Colorimetric assay for number of murine aortic SMCs adherent to fibronectin-coated plates after 1 hour following cell pretreatment with vehicle, AngII at 100 nM, and/or rapamycin at 100 ng/mL for 45 minutes (n = 9–10, pooled from 3 experiments); OD405 readings normalized to vehicle-treated controls. (E) Similar fibronectin adhesion assay of SMCs pretreated with CTGF, thrombospondin-1, or tenascin-C at various doses for 45 minutes (n = 5–10, pooled from 3 experiments). (F) Colorimetric assay for number of SMCs adherent to plates coated with CTGF, thrombospondin-1, or tenascin-C at various concentrations (in the absence of fibronectin) after 1 hour (n = 2). (G) CTGF adhesion assay of SMCs pretreated with blocking antibody to integrin α5 (Itga5 Ab) or isotype-matched control antibody (Ctrl Ab) for 45 minutes (n = 10–11, pooled from 3 experiments). (H) Fibronectin adhesion assay of human aortic SMCs from 3 individuals pretreated with CTGF at various doses for 45 minutes (n = 4, shown separately for each subject). Individual data shown, bars represent mean ± SEM or lines represent nonlinear regression fitting by least-squares regression, **P < 0.01, ***P < 0.001, unpaired, 2-tailed t test (G), 1‑way ANOVA with Tukey’s multiple-comparison test (C–E and H), and 2‑way ANOVA with Sidak’s multiple-comparison test (B).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts